iSpecimen Inc. (ISPC) NASDAQ
$0.24 (0.01) (-4.00%)
Market Cap: $3.17M
As of 09/11/24 04:00 PM EDT. Market closed.
iSpecimen Inc. (ISPC)
NASDAQ
$0.24
(0.01) (-4.00%)
Market Cap: $3.17M
As of 09/11/24 04:00 PM EDT. Market closed.
Add to Portfolio
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Ms. Tracy Wilson Curley
Full Time Employees
53
CEO Compensation (Base)
$350,000
CEO Compensation (Total)
$437,500
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Ms. Tracy Wilson Curley
Full Time Employees
53
CEO Compensation (Base)
$350,000
CEO Compensation (Total)
$437,500
Address
450 Bedford Street, MA, Lexington, 02420.
PRICE CHART FOR ISPECIMEN INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.25
Previous Close
$0.25
Days Range
$0.23 - $0.27
52 week range
$0.20 - $0.79
Volume
1,007,883
Avg. Volume (30 days)
1,941,891
Market Cap
$3.17M
Dividend Yield
-
P/E
(0.23)
Shares Outstanding
13,097,000
Open
$0.25
Previous Close
$0.25
Days Range
$0.23 - $0.27
52 week range
$0.20 - $0.79
Volume
1,007,883
Avg. Volume (30 days)
1,941,891
Market Cap
$3.17M
Dividend Yield
-
P/E
(0.23)
Shares Outstanding
13,097,000
FINANCIAL STATEMENTS FOR ISPECIMEN INC.
LOADING...
INSIDER TRANSACTIONS FOR ISPECIMEN INC.
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Bielak Benjamin | Chief Info Officer & Secretary | Sep 14, 2023 | Buy | $0.72 | 18,000 | 12,960 | 84,348 | Sep 15, 2023, 04:23 PM |
Curley Tracy | CEO, CFO and Treasurer | May 31, 2023 | Buy | $1.25 | 4,400 | 5,500 | 49,541 | Jun 01, 2023, 05:56 PM |
Ianelli Christopher | Director | Jan 06, 2023 | Option Exercise | $1.00 | 845 | 845 | 425,359 | Jan 19, 2023, 06:32 PM |
Mullan Jill | Director | Jan 17, 2023 | Option Exercise | $1.00 | 66,637 | 66,637 | 246,226 | Jan 19, 2023, 04:04 PM |
Curley Tracy | CFO and Treasurer | Jun 22, 2022 | Option Exercise | $2.36 | 2,738 | 6,462 | 45,141 | Jun 24, 2022, 05:14 PM |
Mullan Jill | COO and Secretary | Jun 22, 2022 | Option Exercise | $2.36 | 3,124 | 7,373 | 197,818 | Jun 24, 2022, 05:13 PM |
Ianelli Christopher | CEO and President | Jun 22, 2022 | Option Exercise | $2.36 | 3,903 | 9,211 | 442,743 | Jun 24, 2022, 05:13 PM |
Bielak Benjamin | Chief Information Officer | Jun 22, 2022 | Option Exercise | $2.36 | 3,148 | 7,429 | 66,348 | Jun 24, 2022, 05:12 PM |
Ianelli Christopher | President & CEO | Feb 23, 2022 | Option Exercise | $1.00 | 48,106 | 48,106 | 446,646 | Feb 24, 2022, 05:00 PM |
Ianelli Christopher | President & CEO | Feb 22, 2022 | Option Exercise | $1.00 | 3,099 | 3,099 | 398,540 | Feb 24, 2022, 05:00 PM |
Mullan Jill | COO & Secretary | Feb 22, 2022 | Option Exercise | $1.00 | 22,395 | 22,395 | 200,942 | Feb 23, 2022, 05:20 PM |
Ross Andrew L. | Director | Nov 08, 2021 | Buy | $5.73 | 1,000 | 5,730 | 1,312,024 | Nov 29, 2021, 08:01 PM |
Ross Andrew L. | Director | Jun 23, 2021 | Buy | $6.52 | 400 | 2,608 | 1,311,024 | Nov 29, 2021, 08:01 PM |
Ross Andrew L. | Director | Jun 17, 2021 | Buy | $6.27 | 100 | 627 | 1,310,624 | Nov 29, 2021, 08:01 PM |
Ross Andrew L. | Director | Nov 16, 2021 | Buy | $5.19 | 1,000 | 5,190 | 1,314,524 | Nov 29, 2021, 08:01 PM |
Ross Andrew L. | Director | Nov 15, 2021 | Buy | $5.30 | 1,000 | 5,295 | 1,313,524 | Nov 29, 2021, 08:01 PM |
Ross Andrew L. | Director | Nov 10, 2021 | Buy | $5.85 | 500 | 2,925 | 1,312,524 | Nov 29, 2021, 08:01 PM |
Curley Tracy | Chief Financial Officer | Nov 17, 2021 | Buy | $5.12 | 2,000 | 10,240 | 10,000 | Nov 17, 2021, 08:01 PM |
Curley Tracy | Chief Financial Officer | Nov 16, 2021 | Buy | $5.23 | 8,000 | 41,840 | 8,000 | Nov 17, 2021, 08:01 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Bielak Benjamin | Chief Info Officer & Secretary | 09/14/2023 | 12,960 |
Curley Tracy | CEO, CFO and Treasurer | 05/31/2023 | 5,500 |
Ianelli Christopher | Director | 01/06/2023 | 845 |
Mullan Jill | Director | 01/17/2023 | 66,637 |
Curley Tracy | CFO and Treasurer | 06/22/2022 | 6,462 |
Mullan Jill | COO and Secretary | 06/22/2022 | 7,373 |
Ianelli Christopher | CEO and President | 06/22/2022 | 9,211 |
Bielak Benjamin | Chief Information Officer | 06/22/2022 | 7,429 |
Ianelli Christopher | President & CEO | 02/23/2022 | 48,106 |
Ianelli Christopher | President & CEO | 02/22/2022 | 3,099 |
Mullan Jill | COO & Secretary | 02/22/2022 | 22,395 |
Ross Andrew L. | Director | 11/08/2021 | 5,730 |
Ross Andrew L. | Director | 06/23/2021 | 2,608 |
Ross Andrew L. | Director | 06/17/2021 | 627 |
Ross Andrew L. | Director | 11/16/2021 | 5,190 |
Ross Andrew L. | Director | 11/15/2021 | 5,295 |
Ross Andrew L. | Director | 11/10/2021 | 2,925 |
Curley Tracy | Chief Financial Officer | 11/17/2021 | 10,240 |
Curley Tracy | Chief Financial Officer | 11/16/2021 | 41,840 |
Load More Insider Transactions
FUNDS WITH A POSITION IN ISPECIMEN INC.
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 56,538 | 0% | No change | Other |
GEODE CAPITAL MANAGEMENT, LLC | 38,498 | 0% | No change | Other |
RENAISSANCE TECHNOLOGIES LLC | 10,000 | 0% | Exited | Other |
CHANGE IN SHARES OUTSTANDING FOR ISPECIMEN INC.
STOCK BUYBACKS FOR ISPECIMEN INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
0.62%
1Q
09/30/2023
0.74%
2Q
06/30/2023
1.09%
3Q
03/31/2023
1.69%
4Q
12/31/2022
2.50%
5Q
09/30/2022
2.86%
6Q
06/30/2022
3.52%
7Q
03/31/2022
4.19%
8Q
09/30/2021
31.21%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ISPECIMEN INC.
LOADING...